💉 Tirzepatide – 10 MG / PEN – Spectrum PHARMA
💉 Product Type
Dual GIP / GLP-1 Receptor Agonist / Prefilled Injectable Pen
💉 Active Ingredient
Tirzepatide
Formula: C₂₂₅H₃₄₈N₄₈O₆₈
💉 Description
Tirzepatide 10 MG Pen by Spectrum PHARMA is a long-acting dual GIP and GLP-1 receptor agonist designed to support weight management, glucose regulation, and metabolic health. Unlike single GLP-1 receptor agonists, Tirzepatide activates both Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors, providing comprehensive metabolic effects.
Supplied in a convenient prefilled injection pen, each pen contains 10 MG of Tirzepatide in a ready-to-use formulation, eliminating the need for reconstitution before administration.
💉 Composition & Form
Active Ingredient: Tirzepatide
Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Strength: 10 MG per pen
Form: Ready-to-use injectable solution
Presentation: 1 prefilled pen
Administration: Subcutaneous injection
💉 Mechanism of Action (How It Works)
Activates GLP-1 receptors to enhance satiety and reduce appetite.
Stimulates GIP receptors, improving insulin secretion in a glucose-dependent manner.
Slows gastric emptying, helping prolong fullness after meals.
Supports healthy blood glucose regulation.
Promotes fat metabolism and body-weight reduction.
Helps preserve lean body mass during weight-loss programs.
💉 Key Benefits
✅ Supports effective weight management
✅ Helps regulate blood glucose levels
✅ Reduces appetite and promotes satiety
✅ Improves insulin sensitivity and metabolic function
✅ Supports fat loss while preserving lean muscle mass
✅ Convenient ready-to-use prefilled pen
💉 Side Effects
⚠ Nausea
⚠ Vomiting
⚠ Diarrhea or constipation
⚠ Abdominal discomfort
⚠ Reduced appetite
⚠ Injection-site irritation
⚠ Fatigue or headache in some individuals
💉 Contraindications
❌ Pregnancy or breastfeeding
❌ History of medullary thyroid carcinoma (MTC)
❌ Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
❌ Known hypersensitivity to Tirzepatide or formulation components
❌ Severe gastrointestinal disease unless medically supervised
💉 Technical Summary
| Property | Details |
|---|---|
| Scientific Name | Tirzepatide |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Classification | Dual GIP / GLP-1 Receptor Agonist |
| Dosage Form | Prefilled Injectable Pen |
| Strength | 10 MG / Pen |
| Administration | Subcutaneous Injection |
| Storage | Refrigerate at 2–8°C. Do not freeze. |
| Formulation | Ready-to-use |
💉 Manufacturer
Spectrum PHARMA
| Brands | Spectrum PHARMA |